New Report Details the Dynamics of the Global Cytology and HPV Testing Markets

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/d5568c/cytology_and_hpv_t)
has announced the addition of the "Cytology and HPV Testing World
Markets" report to their offering.

Cancer is a group of diseases characterized by uncontrolled growth
and spread of abnormal cells. If the spread is not controlled, it can
result in death. Cancer is caused by both external (chemicals,
radiation and viruses) and internal (hormones, immune conditions and
inherited mutations) factors. Causal factors may act together or in
sequence to initiate or promote carcinogenesis. Ten or more years
often pass between exposures or mutations and detectable cancer.
Cancer is treated by surgery, radiation, chemotherapy, hormones and
immunotherapy. The purpose of this TriMark Publications report is to
describe the specific segment of the diagnostic market aimed at
analysis cytology (the examination of cells using optical microscopy
methods) specimens derived from the human female reproductive tract.

It examines the measurement devices and their reagents and
supplies used in hospitals, clinics, commercial laboratories and
research institutions to detect cells and proteins for the diagnosis
and monitoring of disease. The study describes the analytical methods
used to separate, isolate, characterize and quantitate cells, DNA and
proteins complex in biological systems related to the diagnosis and
treatment of disease of the female reproductive tract, such as the
cervix and vagina. The emphasis is on those companies and products
that are actively developing and marketing laboratory instrumentation,
reagents and supplies for performing cytology and related molecular
diagnostic tests, such as human papillomavirus (HPV) and other
inflammatory and sexually-transmitted diseases.

Key Topics Covered:

- Overview

- Introduction to Cancer Biology and the Diagnostic Industry

- Cervical Cytology Testing Overview

- Human Papillomavirus (HPV) Testing Overview

- Cytology Market Structure

- Human Papillomavirus (HPV) Testing Market Structure

- Business Trends in the Industry

- Government Regulation

- Legal Developments

- Third-Party Reimbursement

- Barriers in Business

- Acquisition Activity

- Research & Development Activity

- Intellectual Property

- Hologic and Cytyc Profile

- Analytical Section

- Industry/Market Landscape

- QIAGEN

- Industry/Market Landscape

- Analytical Section

- Industry/Market Landscape

For more information visit
http://www.researchandmarkets.com/research/d5568c/cytology_and_hpv_t

Research and Markets
Laura Wood
Senior Manager
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com

Copyright Business Wire 2008